Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • GENERAL HEALTH CARE NEWS—E.D.N.Y.: Surgery practice’s challenge to No Surprises Act dismissed
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: DMEPOS Supplier had no right to review duration of CMS revocation
    • ADMINISTRATION OF THE FDC ACT—NOTICES: FDA revokes EUAs for multiple COVID-19 tests approved during the COVID-19 pandemic
    • ADVERTISING (FOOD, DRUG & MEDICAL DEVICES)—N.D. Cal.: Class certification denied in consumer protection case over ghee food labels
    • AUDITS AND MONITORING—OIG REPORTS: HHS falls short of full compliance with PIIA for FY 2024
    • CONTROLLED SUBSTANCES—NOTICES: Importer debarred for selling non-FDA approved drugs
    • ELECTRONIC HEALTH RECORDS—SETTLEMENT AGREEMENTS: Medical Record Data Breach Leads to Fine for Health Care Provider
    • EXPERT INSIGHTS: CMS to immediately begin auditing Medicare Advantage plans in significant expansion of enforcement efforts
    • GENERAL HEALTH CARE NEWS—GAO REPORTS: GAO addresses Congress’ concerns regarding caregiving youth issues
    • HEALTH CARE EMPLOYMENT ISSUES—D. Md.: Evidentiary requests denied in COVID-19 vaccine mandate religious discrimination case
    • HEALTH CARE EMPLOYMENT ISSUES—W.D. Va.: Lawsuit alleging COVID-19 vaccine religious discrimination dismissed in part
    • HIPAA—SETTLEMENT AGREEMENTS: OCR settles HIPAA cybersecurity investigation with small health care provider
    • LAW FIRM NEWS—Noteworthy developments in the legal community
    • MISBRANDING (FOOD, DRUGS & MEDICAL DEVICES)—NOTICES: Importer debarred for offering for sale misbranded male enhancement drugs
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Health Law Daily Wrap Up, AUDITS AND MONITORING—OIG REPORTS: HHS falls short of full compliance with PIIA for FY 2024, (May 30, 2025)

    Organizations Mentioned:Ernst & Young LLP

    By Elena Eyber, J.D.

    HHS met several requirements under the Payment Integrity Information Act but failed full compliance due to gaps in risk assessments and audit recovery.

    The Office of Inspector General (OIG) has found that HHS did not fully comply with the Payment Inte ...

    By Elena Eyber, J.D.

    HHS met several requirements under the Payment Integrity Information Act but failed full compliance due to gaps in risk assessments and audit recovery.

    The Office of Inspector General (OIG) has found that HHS did not fully comply with the Payment Integrity Information Act of 2019 (PIIA) for fiscal year 2024. In an independent audit conducted by Ernst & Young LLP, it was determined that while HHS satisfied many PIIA requirements, such as publishing improper payment estimates and reporting financial information, it fell short in other key areas. These gaps in compliance were identified despite adherence to guidelines issued by the Office of Management and Budget and generally accepted government auditing standards (OIG Report, No. OAS-25-17-042 (May. 19, 2025)).

    A primary shortcoming noted was HHS’ failure to conduct timely risk assessments for all programs with annual outlays exceeding $10 million, a requirement meant to identify susceptibility to improper and unknown payments. Though HHS assessed 89 programs based on FY 2023 outlays, it did not fulfill the statutory mandate to evaluate each qualifying program at least once every three years. This lapse undermines the HHS’ capacity to detect and reduce financial mismanagement across its numerous programs.

    Further, the audit highlighted a significant deficiency related to recovery efforts. Specifically, HHS had not completed required recovery audit activities for improper payments identified in the Medicare Advantage (Part C) program. This noncompliance raised concerns regarding HHS' effectiveness in addressing overpayments and ensuring fiscal accountability, especially in high-priority programs like Medicaid, CHIP, and Medicare.

    According to the audit, while HHS has demonstrated progress in meeting many aspects of PIIA and maintaining internal control frameworks, these compliance failures suggest a need for stronger oversight and follow-through on statutory obligations. The OIG's report underscores the importance of consistent risk assessment, proper documentation, and timely recovery actions to ensure transparency and stewardship of taxpayer resources.

    ReportsLetters: OIGReports CMSNews AuditNews ProgramIntegrityNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use